You just read:

Mylan Announces U.S. FDA Approval of First Generic for Copaxone® 40 mg/mL 3-Times-a-Week and May Be Eligible for 180-Day Exclusivity

News provided by

Mylan N.V.

Oct 03, 2017, 20:08 ET